DRAPER, Utah, Nov. 14, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company has acquired the exclusive North American sales and distribution rights to the Nutriband delivery system, an innovative and commercialized health supplement transdermal patch system currently available in Europe.
"The Nutriband delivery system is cutting-edge science that allows delivery of vitamins, minerals, amino acids, and other health supplements safely and effectively through an innovative transdermal skin patch, without the need to swallow chalky coated tablets, large capsules, or powders," stated Nutranomics' CEO Dr. Tracy K. Gibbs. "We intend to utilize our substantial new product development experience to build out a much wider product line based on the Nutriband technology, including Nutranomics transdermal patches designed to improve sleep, manage pain, boost energy, and control weight."
Dr. Gibbs concluded, "The possibility for new Nutranomics branded products based on the Nutriband transdermal delivery system technology is absolutely enormous. The planned combination of this unique time-release delivery method within our current and future product lineup should help to further distinguish Nutranomics as an innovative industry leader as we continue our expansion strategies globally."
Nutriband transdermal patches are designed on the principle that many nutrients can be absorbed not only orally, but through the skin as well. The medical industry has utilized this principle for many years to deliver angina medication, hormone replacement, and nicotine therapy among others. The delivery of nutrients directly through the skin bypasses the harsh conditions of the stomach before being absorbed into the blood stream. Nutriband has successfully applied this method to various vitamins, minerals, amino acids, and other health supplements. Nutriband supplement patches have the added benefit that nutrients are absorbed over a sustained period of time (up to 6 hours) for optimal efficacy and do not contain any of the additives or preservatives frequently found in nutritional supplements.
For additional information and video regarding Nutriband, visit www.nutriband.com/about/.
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at firstname.lastname@example.org or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's intent to acquire a GenEpic™ distribution licence, the completion human clinical trials, and conducting future GenEpic™ research regarding other forms of cancer. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.